ArticleScientific reports2020

Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.

Sabina Luszczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.